5F-ADB

Overview

Chemical structure of 5F-ADB

5F-ADB (also known as 5F-MDMB-PINACA) is a synthetic cannabinoid that has been used as an active ingredient in synthetic cannabis products. It is a potent agonist of the cannabinoid receptors and has been associated with numerous adverse health effects.

Chemical Properties

5F-ADB is classified as an indazole-based synthetic cannabinoid. Its chemical structure includes a fluoropentyl chain, which is a common feature in many synthetic cannabinoids. The presence of the fluorine atom is believed to enhance its potency and metabolic stability.

Pharmacology

5F-ADB acts as a full agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as mood, appetite, and pain sensation.

Effects and Toxicity

The effects of 5F-ADB are similar to those of other synthetic cannabinoids, including euphoria, relaxation, and altered perception. However, it can also cause severe adverse effects such as tachycardia, hypertension, nausea, vomiting, anxiety, and hallucinations. In some cases, it has been linked to acute kidney injury and death.

Legal Status

Due to its potential for abuse and harmful effects, 5F-ADB has been classified as a controlled substance in many countries. It is often included in the list of substances banned under analogue drug laws.

Synthesis and Detection

The synthesis of 5F-ADB involves the reaction of an indazole core with a fluoropentyl chain and a carboxamide group. Detection of 5F-ADB in biological samples can be challenging due to its rapid metabolism, but advanced techniques such as mass spectrometry and gas chromatography are used for its identification.

Related Compounds

5F-ADB is structurally related to other synthetic cannabinoids such as AB-FUBINACA, ADB-FUBINACA, and 5F-AMB. These compounds share similar pharmacological profiles and are often found in synthetic cannabis products.

Related Pages

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Drug metabolism